FXM Research consists of a group of professionals whose only aim is to deliver consistent high-quality service to respected Pharmaceutical Companies and CROs conducting research in Dermatology across the US and over International waters.
We offer experienced, trained, and bilingual personnel (English and Spanish), who interact with our subjects, sponsors, and CROs as a cohesive team.
Our Principal Investigators are Board Certified Dermatologists and Certified Clinical Research Investigators with many years of extensive experience. They are located onsite and are available full-time.
Our Mission
At the core of our business and operating systems, FXM Research mission is to support pharmaceutical companies and CROs with introducing new and approved FDA medications successfully into the marketplace. We perform this efficiently and effectively by providing the highest quality service in a timely fashion and at the lowest possible cost.
We specialize in conducting phase II, III, and IV Dermatology Clinical Trials. Our primary concerns are subject safety and adherence to the protocol. Turnover time for Regulatory Documents, budgets, and contracts is usually 24 to 48 hours.
